Thermo Fisher Scientific Inc., of Carlsbad, Calif., said it licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property portfolio. Under the terms of the licenses, Thermo Fisher is granted global nonexclusive rights to products, tools and services for research.